{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:07:04Z","timestamp":1787929624283,"version":"build-2784847793"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00120-020-01368-6","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T13:02:47Z","timestamp":1602507767000},"page":"1463-1471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Die Rolle des Mikrobioms in der Urologie","The role of the microbiome in urology"],"prefix":"10.1007","volume":"59","author":[{"given":"G.","family":"Magistro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Marcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Eismann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Volz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. G.","family":"Stief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"issue":"7402","key":"1368_CR1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"Human Microbiome Project C","year":"2012","unstructured":"Human Microbiome Project C (2012) Structure, function and diversity of the healthy human microbiome. Nature 486(7402):207\u2013214","journal-title":"Nature"},{"issue":"7402","key":"1368_CR2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature11209","volume":"486","author":"Human Microbiome Project C","year":"2012","unstructured":"Human Microbiome Project C (2012) A framework for human microbiome research. Nature 486(7402):215\u2013221","journal-title":"Nature"},{"issue":"1","key":"1368_CR3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.euf.2018.06.011","volume":"5","author":"G Magistro","year":"2019","unstructured":"Magistro\u00a0G, Stief\u00a0CG (2019) The urinary tract microbiome: the answer to all our open questions? Eur Urol Focus 5(1):36\u201338","journal-title":"Eur Urol Focus"},{"issue":"1","key":"1368_CR4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrurol.2017.167","volume":"15","author":"KS Sfanos","year":"2018","unstructured":"Sfanos\u00a0KS, Yegnasubramanian\u00a0S, Nelson\u00a0WG, De Marzo\u00a0AM (2018) The inflammatory microenvironment and microbiome in prostate cancer development. Nat Rev Urol 15(1):11\u201324","journal-title":"Nat Rev Urol"},{"issue":"6","key":"1368_CR5","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1097\/01.ju.0000158161.15277.78","volume":"173","author":"RJ Cohen","year":"2005","unstructured":"Cohen\u00a0RJ, Shannon\u00a0BA, McNeal\u00a0JE, Shannon\u00a0T, Garrett\u00a0KL (2005) Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a\u00a0possible link to cancer evolution? J\u00a0Urol 173(6):1969\u20131974","journal-title":"J Urol"},{"issue":"4","key":"1368_CR6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.eururo.2017.03.029","volume":"72","author":"I Cavarretta","year":"2017","unstructured":"Cavarretta\u00a0I, Ferrarese\u00a0R, Cazzaniga\u00a0W, Saita\u00a0D, Luciano\u00a0R, Ceresola\u00a0ER et\u00a0al (2017) The microbiome of the prostate tumor microenvironment. Eur Urol 72(4):625\u2013631","journal-title":"Eur Urol"},{"issue":"1","key":"1368_CR7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12864-019-5457-z","volume":"20","author":"Y Feng","year":"2019","unstructured":"Feng\u00a0Y, Ramnarine\u00a0VR, Bell\u00a0R, Volik\u00a0S, Davicioni\u00a0E, Hayes\u00a0VM et\u00a0al (2019) Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer. BMC Genomics 20(1):146","journal-title":"BMC Genomics"},{"issue":"6","key":"1368_CR8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/carcin\/bgz008","volume":"40","author":"S Banerjee","year":"2019","unstructured":"Banerjee\u00a0S, Alwine\u00a0JC, Wei\u00a0Z, Tian\u00a0T, Shih\u00a0N, Sperling\u00a0C et\u00a0al (2019) Microbiome signatures in prostate cancer. Carcinogenesis 40(6):749\u2013764","journal-title":"Carcinogenesis"},{"key":"1368_CR9","doi-asserted-by":"publisher","unstructured":"Miyake M, Ohnishi K, Hori S, Nakano A, Nakano R, Yano H et\u00a0al (2019) Mycoplasma genitalium infection and chronic inflammation in human prostate cancer: detection using prostatectomy and needle biopsy specimens. Cells 8(3):212. https:\/\/doi.org\/10.3390\/cells8030212","DOI":"10.3390\/cells8030212"},{"issue":"5","key":"1368_CR10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.eururo.2018.06.033","volume":"74","author":"MA Liss","year":"2018","unstructured":"Liss\u00a0MA, White\u00a0JR, Goros\u00a0M, Gelfond\u00a0J, Leach\u00a0R, Johnson-Pais\u00a0T et al (2018) Metabolic biosynthesis pathways identified from fecal microbiome associated with prostate cancer. Eur Urol 74(5):575\u2013582","journal-title":"Eur Urol"},{"key":"1368_CR11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2017.08.039","volume":"111","author":"DM Golombos","year":"2018","unstructured":"Golombos\u00a0DM, Ayangbesan\u00a0A, O\u2019Malley\u00a0P, Lewicki\u00a0P, Barlow\u00a0L, Barbieri\u00a0CE et\u00a0al (2018) The role of gut microbiome in the pathogenesis of prostate cancer: a prospective, pilot study. Urology 111:122\u2013128","journal-title":"Urology"},{"issue":"4","key":"1368_CR12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41391-018-0061-x","volume":"21","author":"KS Sfanos","year":"2018","unstructured":"Sfanos\u00a0KS, Markowski\u00a0MC, Peiffer\u00a0LB, Ernst\u00a0SE, White\u00a0JR, Pienta\u00a0KJ et al (2018) Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies. Prostate Cancer Prostatic Dis 21(4):539\u2013548","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3\u20134","key":"1368_CR13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000504029","volume":"104","author":"S Heidler","year":"2020","unstructured":"Heidler\u00a0S, Lusuardi\u00a0L, Madersbacher\u00a0S, Freibauer\u00a0C (2020) The microbiome in benign renal tissue and in renal cell carcinoma. Urol Int 104(3\u20134):247\u2013252","journal-title":"Urol Int"},{"issue":"2","key":"1368_CR14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ucl.2004.01.004","volume":"31","author":"R Dhote","year":"2004","unstructured":"Dhote\u00a0R, Thiounn\u00a0N, Debre\u00a0B, Vidal-Trecan\u00a0G (2004) Risk factors for adult renal cell carcinoma. Urol Clin North Am 31(2):237\u2013247","journal-title":"Urol Clin North Am"},{"issue":"1","key":"1368_CR15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/aje\/kwh014","volume":"159","author":"AS Parker","year":"2004","unstructured":"Parker\u00a0AS, Cerhan\u00a0JR, Lynch\u00a0CF, Leibovich\u00a0BC, Cantor\u00a0KP (2004) History of urinary tract infection and risk of renal cell carcinoma. Am J Epidemiol 159(1):42\u201348","journal-title":"Am J Epidemiol"},{"issue":"5","key":"1368_CR16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.clgc.2018.05.001","volume":"16","author":"AW Hahn","year":"2018","unstructured":"Hahn\u00a0AW, Froerer\u00a0C, VanAlstine\u00a0S, Rathi\u00a0N, Bailey\u00a0EB, Stenehjem\u00a0DD et al (2018) Targeting bacteroides in stool microbiome and response to treatment with first-line VEGF tyrosine kinase inhibitors in metastatic renal-cell carcinoma. Clin Genitourin Cancer 16(5):365\u2013368","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"1368_CR17","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdy103","volume":"29","author":"L Derosa","year":"2018","unstructured":"Derosa\u00a0L, Hellmann\u00a0MD, Spaziano\u00a0M, Halpenny\u00a0D, Fidelle\u00a0M, Rizvi\u00a0H et al (2018) Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer. Ann Oncol 29(6):1437\u20131444","journal-title":"Ann Oncol"},{"issue":"3","key":"1368_CR18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.euo.2019.09.001","volume":"3","author":"AA Lalani","year":"2020","unstructured":"Lalani\u00a0AA, Xie\u00a0W, Braun\u00a0DA, Kaymakcalan\u00a0M, Bosse\u00a0D, Steinharter\u00a0JA et\u00a0al (2020) Effect of antibiotic use on outcomes with systemic therapies in metastatic renal cell carcinoma. Eur Urol Oncol 3(3):372\u2013381","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"1368_CR19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1634\/theoncologist.2019-0160","volume":"25","author":"N Tinsley","year":"2020","unstructured":"Tinsley\u00a0N, Zhou\u00a0C, Tan\u00a0G, Rack\u00a0S, Lorigan\u00a0P, Blackhall\u00a0F et\u00a0al (2020) Cumulative antibiotic use significantly decreases efficacy of checkpoint inhibitors in patients with advanced cancer. Oncologist 25(1):55\u201363","journal-title":"Oncologist"},{"issue":"11","key":"1368_CR20","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.21873\/anticanres.13836","volume":"39","author":"K Ueda","year":"2019","unstructured":"Ueda\u00a0K, Yonekura\u00a0S, Ogasawara\u00a0N, Matsunaga\u00a0Y, Hoshino\u00a0R, Kurose\u00a0H et\u00a0al (2019) The impact of antibiotics on prognosis of metastatic renal cell carcinoma in Japanese patients treated with immune checkpoint inhibitors. Anticancer Res 39(11):6265\u20136271","journal-title":"Anticancer Res"},{"issue":"3","key":"1368_CR21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00262-019-02453-2","volume":"69","author":"BE Wilson","year":"2020","unstructured":"Wilson\u00a0BE, Routy\u00a0B, Nagrial\u00a0A, Chin\u00a0VT (2020) The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a\u00a0systematic review and meta-analysis of observational studies. Cancer Immunol Immunother 69(3):343\u2013354","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"1368_CR22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.eururo.2020.04.044","volume":"78","author":"L Derosa","year":"2020","unstructured":"Derosa\u00a0L, Routy\u00a0B, Fidelle\u00a0M, Iebba\u00a0V, Alla\u00a0L, Pasolli\u00a0E et\u00a0al (2020) Gut bacteria composition drives primary resistance to cancer immunotherapy in renal cell carcinoma patients. Eur Urol 78(2):195\u2013206","journal-title":"Eur Urol"},{"key":"1368_CR23","doi-asserted-by":"publisher","unstructured":"Salgia NJ, Bergerot PG, Maia MC, Dizman N, Hsu J, Gillece JD et al (2020) Stool microbiome profiling of patients with metastatic renal cell carcinoma receiving anti-PD\u20111 immune checkpoint inhibitors. Eur Urol 78(4):498\u2013502. https:\/\/doi.org\/10.1016\/j.eururo.2020.07.011","DOI":"10.1016\/j.eururo.2020.07.011"},{"key":"1368_CR24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fcimb.2018.00167","volume":"8","author":"P Wu","year":"2018","unstructured":"Wu\u00a0P, Zhang\u00a0G, Zhao\u00a0J, Chen\u00a0J, Chen\u00a0Y, Huang\u00a0W et\u00a0al (2018) Profiling the urinary microbiota in male patients with bladder cancer in China. Front Cell Infect Microbiol 8:167","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"1368_CR25","doi-asserted-by":"crossref","first-page":"12157","DOI":"10.1038\/s41598-018-29054-w","volume":"8","author":"V Bucevic Popovic","year":"2018","unstructured":"Bucevic Popovic\u00a0V, Situm\u00a0M, Chow\u00a0CT, Chan\u00a0LS, Roje\u00a0B, Terzic\u00a0J (2018) The urinary microbiome associated with bladder cancer. Sci Rep 8(1):12157","journal-title":"Sci Rep"},{"key":"1368_CR26","doi-asserted-by":"publisher","unstructured":"Bilski K, Dobruch J, Kozikowski M, Skrzypczyk MA, Oszczudlowski M, Ostrowski J (2020) Urobiome in gender-related diversities of bladder cancer. Int J Mol Sci 21(12):4488. https:\/\/doi.org\/10.3390\/ijms21124488","DOI":"10.3390\/ijms21124488"},{"issue":"1","key":"1368_CR27","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1038\/s41598-020-67443-2","volume":"10","author":"B Mansour","year":"2020","unstructured":"Mansour\u00a0B, Monyok\u00a0A, Makra\u00a0N, Gajdacs\u00a0M, Vadnay\u00a0I, Ligeti\u00a0B et al (2020) Bladder cancer-related microbiota: examining differences in urine and tissue samples. Sci Rep 10(1):11042","journal-title":"Sci Rep"},{"key":"1368_CR28","doi-asserted-by":"publisher","unstructured":"Oresta B, Braga D, Lazzeri M, Frego N, Saita A, Faccani C et al (2020) The microbiome of catheter-collected urine in males with bladder cancer according to disease stage. J\u00a0Urol. https:\/\/doi.org\/10.1097\/JU.0000000000001336","DOI":"10.1097\/JU.0000000000001336"},{"issue":"16","key":"1368_CR29","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1002\/cam4.2419","volume":"8","author":"F Liu","year":"2019","unstructured":"Liu\u00a0F, Liu\u00a0A, Lu\u00a0X, Zhang\u00a0Z, Xue\u00a0Y, Xu\u00a0J et\u00a0al (2019) Dysbiosis signatures of the microbial profile in tissue from bladder cancer. Cancer Med 8(16):6904\u20136914","journal-title":"Cancer Med"},{"key":"1368_CR30","first-page":"4824909","volume":"2019","author":"G Mai","year":"2019","unstructured":"Mai\u00a0G, Chen\u00a0L, Li\u00a0R, Liu\u00a0Q, Zhang\u00a0H, Ma\u00a0Y (2019) Common core bacterial biomarkers of bladder cancer based on multiple datasets. Biomed Res Int 2019:4824909","journal-title":"Biomed Res Int"},{"key":"1368_CR31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1471-2180-12-205","volume":"12","author":"H Siddiqui","year":"2012","unstructured":"Siddiqui\u00a0H, Lagesen\u00a0K, Nederbragt\u00a0AJ, Jeansson\u00a0SL, Jakobsen\u00a0KS (2012) Alterations of microbiota in urine from women with interstitial cystitis. BMC Microbiol 12:205","journal-title":"BMC Microbiol"},{"key":"1368_CR32","doi-asserted-by":"publisher","unstructured":"Nickel JC, Stephens-Shields AJ, Landis JR, Mullins C, van Bokhoven A, Lucia MS et al (2019) A culture-independent analysis of the microbiota of female interstitial cystitis\/bladder pain syndrome participants in the MAPP research network. J\u00a0Clin Med 8(3):415. https:\/\/doi.org\/10.3390\/jcm8030415","DOI":"10.3390\/jcm8030415"},{"issue":"3","key":"1368_CR33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/AOG.0000000000001892","volume":"129","author":"MG Abernethy","year":"2017","unstructured":"Abernethy\u00a0MG, Rosenfeld\u00a0A, White\u00a0JR, Mueller\u00a0MG, Lewicky-Gaupp\u00a0C, Kenton\u00a0K (2017) Urinary microbiome and cytokine levels in women with interstitial cystitis. Obstet Gynecol 129(3):500\u2013506","journal-title":"Obstet Gynecol"},{"key":"1368_CR34","doi-asserted-by":"publisher","unstructured":"Jacobs KM, Price TK, Thomas-White K, Halverson T, Davies A, Myers DL et al (2020) Cultivable bacteria in urine of women with interstitial cystitis: (not) what we expected. Female Pelvic Med Reconstr Surg. https:\/\/doi.org\/10.1097\/SPV.0000000000000854","DOI":"10.1097\/SPV.0000000000000854"},{"key":"1368_CR35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fcimb.2019.00092","volume":"9","author":"KV Meriwether","year":"2019","unstructured":"Meriwether\u00a0KV, Lei\u00a0Z, Singh\u00a0R, Gaskins\u00a0J, Hobson\u00a0DTG, Jala\u00a0V (2019) The vaginal and urinary microbiomes in premenopausal women with interstitial cystitis\/bladder pain syndrome as compared to unaffected controls: a pilot cross-sectional study. Front Cell Infect Microbiol 9:92","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"1368_CR36","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00192-019-03942-9","volume":"30","author":"L Bresler","year":"2019","unstructured":"Bresler\u00a0L, Price\u00a0TK, Hilt\u00a0EE, Joyce\u00a0C, Fitzgerald\u00a0CM, Wolfe\u00a0AJ (2019) Female lower urinary tract microbiota do not associate with IC\/PBS symptoms: a\u00a0case-controlled study. Int Urogynecol\u00a0J 30(11):1835\u20131842","journal-title":"Int Urogynecol J"},{"issue":"2","key":"1368_CR37","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.juro.2015.09.075","volume":"195","author":"JC Nickel","year":"2016","unstructured":"Nickel\u00a0JC, Stephens\u00a0A, Landis\u00a0JR, Mullins\u00a0C, van Bokhoven\u00a0A, Lucia\u00a0MS et\u00a0al (2016) Assessment of the lower urinary tract microbiota during symptom flare in women with urologic chronic pelvic pain syndrome: a MAPP network study. J\u00a0Urol 195(2):356\u2013362","journal-title":"J Urol"},{"issue":"3","key":"1368_CR38","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.juro.2018.03.133","volume":"200","author":"JF Jhang","year":"2018","unstructured":"Jhang\u00a0JF, Hsu\u00a0YH, Peng\u00a0CW, Jiang\u00a0YH, Ho\u00a0HC, Kuo\u00a0HC (2018) Epstein-Barr virus as a\u00a0potential etiology of persistent bladder inflammation in human interstitial cystitis\/bladder pain syndrome. J\u00a0Urol 200(3):590\u2013596","journal-title":"J Urol"},{"issue":"9","key":"1368_CR39","doi-asserted-by":"crossref","first-page":"e0137310","DOI":"10.1371\/journal.pone.0137310","volume":"10","author":"BJ Winter","year":"2015","unstructured":"Winter\u00a0BJ, O\u2019Connell\u00a0HE, Bowden\u00a0S, Carey\u00a0M, Eisen\u00a0DP (2015) A case control study reveals that polyomaviruria is significantly associated with interstitial cystitis and vesical ulceration. PLoS ONE 10(9):e137310","journal-title":"PLoS ONE"},{"issue":"4","key":"1368_CR40","doi-asserted-by":"crossref","first-page":"e01283","DOI":"10.1128\/mBio.01283-14","volume":"5","author":"MM Pearce","year":"2014","unstructured":"Pearce\u00a0MM, Hilt\u00a0EE, Rosenfeld\u00a0AB, Zilliox\u00a0MJ, Thomas-White\u00a0K, Fok\u00a0C et al (2014) The female urinary microbiome: a\u00a0comparison of women with and without urgency urinary incontinence. mBio 5(4):e1283\u2013e1214","journal-title":"mBio"},{"key":"1368_CR41","doi-asserted-by":"publisher","unstructured":"Thomas-White K, Taege S, Limeira R, Brincat C, Joyce C, Hilt EE et al (2020) Vaginal estrogen therapy is associated with increased Lactobacillus in the urine of postmenopausal women with overactive bladder symptoms. Am J Obstet Gynecol. https:\/\/doi.org\/10.1016\/j.ajog.2020.08.006","DOI":"10.1016\/j.ajog.2020.08.006"},{"issue":"5","key":"1368_CR42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00192-015-2847-x","volume":"27","author":"KJ Thomas-White","year":"2016","unstructured":"Thomas-White\u00a0KJ, Hilt\u00a0EE, Fok\u00a0C, Pearce\u00a0MM, Mueller\u00a0ER, Kliethermes\u00a0S et al (2016) Incontinence medication response relates to the female urinary microbiota. Int Urogynecol\u00a0J 27(5):723\u2013733","journal-title":"Int Urogynecol J"},{"key":"1368_CR43","doi-asserted-by":"publisher","unstructured":"Price TK, Lin H, Gao X, Thomas-White KJ, Hilt EE, Mueller ER et al (2020) Bladder bacterial diversity differs in continent and incontinent women: a\u00a0cross-sectional study. Am J Obstet Gynecol. https:\/\/doi.org\/10.1016\/j.ajog.2020.04.033","DOI":"10.1016\/j.ajog.2020.04.033"},{"key":"1368_CR44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fcimb.2016.00078","volume":"6","author":"L Karstens","year":"2016","unstructured":"Karstens\u00a0L, Asquith\u00a0M, Davin\u00a0S, Stauffer\u00a0P, Fair\u00a0D, Gregory\u00a0WT et\u00a0al (2016) Does the urinary microbiome play a\u00a0role in urgency urinary incontinence and its severity? Front Cell Infect Microbiol 6:78","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"1368_CR45","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00120-020-01226-5","volume":"59","author":"G Magistro","year":"2020","unstructured":"Magistro\u00a0G, Stief\u00a0CG, Wagenlehner\u00a0FME (2020) Chronic prostatitis\/chronic pelvic pain syndrome. Urologe\u00a0A 59(6):739\u2013748","journal-title":"Urologe A"},{"key":"1368_CR46","doi-asserted-by":"publisher","unstructured":"Magistro G, Wagenlehner FM, Grabe M, Weidner W, Stief CG, Nickel JC (2015) Contemporary management of chronic prostatitis\/chronic pelvic pain syndrome. Eur Urol 69(2):286\u2013297. https:\/\/doi.org\/10.1016\/j.eururo.2015.08.061","DOI":"10.1016\/j.eururo.2015.08.061"},{"issue":"5","key":"1368_CR47","first-page":"492","volume":"5","author":"EM Meares","year":"1968","unstructured":"Meares\u00a0EM, Stamey\u00a0TA (1968) Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 5(5):492\u2013518","journal-title":"Invest Urol"},{"issue":"1","key":"1368_CR48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.juro.2015.01.037","volume":"194","author":"JC Nickel","year":"2015","unstructured":"Nickel\u00a0JC, Stephens\u00a0A, Landis\u00a0JR, Chen\u00a0J, Mullins\u00a0C, van Bokhoven\u00a0A et al (2015) Search for microorganisms in men with urologic chronic pelvic pain syndrome: a culture-independent analysis in the MAPP research network. J\u00a0Urol 194(1):127\u2013135","journal-title":"J Urol"},{"key":"1368_CR49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.urology.2016.02.043","volume":"92","author":"DA Shoskes","year":"2016","unstructured":"Shoskes\u00a0DA, Altemus\u00a0J, Polackwich\u00a0AS, Tucky\u00a0B, Wang\u00a0H, Eng\u00a0C (2016) The urinary microbiome differs significantly between patients with chronic prostatitis\/chronic pelvic pain syndrome and controls as well as between patients with different clinical phenotypes. Urology 92:26\u201332","journal-title":"Urology"},{"key":"1368_CR50","doi-asserted-by":"publisher","unstructured":"Shoskes DA, Wang H, Polackwich AS, Tucky B, Altemus J, Eng C (2016) Analysis of gut microbiome reveals significant differences between men with chronic prostatitis\/chronic pelvic pain syndrome and controls. J\u00a0Urol 196(2):435\u2013441. https:\/\/doi.org\/10.1016\/j.juro.2016.02.2959","DOI":"10.1016\/j.juro.2016.02.2959"},{"issue":"3","key":"1368_CR51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/iju.13286","volume":"24","author":"R Mandar","year":"2017","unstructured":"Mandar\u00a0R, Punab\u00a0M, Korrovits\u00a0P, Turk\u00a0S, Ausmees\u00a0K, Lapp\u00a0E et\u00a0al (2017) Seminal microbiome in men with and without prostatitis. Int J Urol 24(3):211\u2013216","journal-title":"Int J Urol"},{"issue":"2","key":"1368_CR52","doi-asserted-by":"crossref","first-page":"398","DOI":"10.21037\/tau.2020.02.05","volume":"9","author":"JB Choi","year":"2020","unstructured":"Choi\u00a0JB, Lee\u00a0SJ, Kang\u00a0SR, Lee\u00a0SS, Choe\u00a0HS (2020) Analysis of bacterial community using pyrosequencing in semen from patients with chronic pelvic pain syndrome: a\u00a0pilot study. Transl Androl Urol 9(2):398\u2013404","journal-title":"Transl Androl Urol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-020-01368-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-020-01368-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-020-01368-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T07:43:28Z","timestamp":1634024608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-020-01368-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1368"],"URL":"https:\/\/doi.org\/10.1007\/s00120-020-01368-6","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]},"assertion":[{"value":"12 October 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"G.\u00a0Magistro, J.\u00a0Marcon, L.\u00a0Eismann, Y.\u00a0Volz und C.G.\u00a0Stief geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}